Western Cape rolls out six-month HIV prevention injection in high-burden communities
The Western Cape in South Africa has begun rolling out a twice-yearly HIV prevention injection, Lenacapavir, to high-burden communities. This initiative aims to provide an effective alternative to daily oral medication, addressing barriers like stigma and economic vulnerability.
Why it matters
Long-acting injectable treatments represent a significant advancement in public health strategies to curb HIV transmission in vulnerable populations.
Fear of side effects, stigma and the challenge of taking a daily pill have long discouraged many adolescent girls and young women from using oral pre-exposure prophylaxis (PrEP), despite its effectiveness in preventing HIV infection.
The article focuses on public health policy and medical innovation, presenting the information objectively.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in